Mobile

A Randomized, Double-Blind, PLacebo-Controlled, Parallel Study to Assess the Efficacy and Safety of Tadalafil (LY450190) Once a Day in Subjects With Erectile Dysfunction Who Are Naive to PDE5 Inhibito...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-004222-17

A Randomized, Double-Blind, PLacebo-Controlled, Parallel Study to Assess the Efficacy and Safety of Tadalafil (LY450190) Once a Day in Subjects With Erectile Dysfunction Who Are Naive to PDE5 Inhibitors

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

- To evaluate the efficacy of tadalafil 5 mg (with possible down-titration to 2.5 mg) compared with placebo, when taken orally once a day over 12 weeks, in improving erectile function in men with ED who are naïve to PDE5 inhibitors. - To assess the safety of tadalafil 5 mg (with possible down-titration to 2.5 mg) administered once a day compared with placebo in men with ED who are naïve to PDE5 inhibitors.

Critère d'inclusion

  • Erectile Dysfunction

Liens